Effects of increased intra-abdominal pressure and volume expansion on renal function in the rat

Background. The effects of increased intra-abdominal pressure (IAP) and volume expansion on renal function in the rat were studied to gain more knowledge of the oliguria seen during laparoscopic procedures and to reduce the detrimental renal effects of IAP. Methods. IAP was elevated to 5 or 10 mmHg...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nephrology, dialysis, transplantation dialysis, transplantation, 2003-11, Vol.18 (11), p.2269-2277
Hauptverfasser: Lindström, Pernilla, Wadström, Jonas, Ollerstam, Anna, Johnsson, Cecilia, Persson, A. Erik G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2277
container_issue 11
container_start_page 2269
container_title Nephrology, dialysis, transplantation
container_volume 18
creator Lindström, Pernilla
Wadström, Jonas
Ollerstam, Anna
Johnsson, Cecilia
Persson, A. Erik G.
description Background. The effects of increased intra-abdominal pressure (IAP) and volume expansion on renal function in the rat were studied to gain more knowledge of the oliguria seen during laparoscopic procedures and to reduce the detrimental renal effects of IAP. Methods. IAP was elevated to 5 or 10 mmHg by insufflation of CO2 and maintained for 2 h in anaesthetized and mechanically ventilated rats. Rats with normal IAP served as controls. An angiotensin II receptor I antagonist, candesartan, was given as a bolus injection and a 5% volume expansion was achieved by i.v. saline infusion. An angiotensin-converting enzyme (ACE) inhibitor was also given. Renal parameters were the glomerular filtration rate (GFR), urine production, the urinary concentrations of sodium and potassium and the osmolality in the urine. The arterial acid–base balance and blood pressure were also monitored. Results. The GFR deteriorated by 70% during pneumoperitoneum (PP) of 10 mmHg. There was a dramatic drop in sodium excretion (88–97%). With candesartan and elevated IAP, there was a drop in mean arterial pressure (from 90 to 55 mmHg) and the negative renal effects were very pronounced. Renal function was better preserved during elevated IAP in combination with volume expansion. Conclusions. Capnoperitoneum suppresses renal function, especially in combination with angiotensin II receptor 1 blockade and ACE inhibition. Volume expansion reduces the deleterious effects of PP on renal function during elevated IAP. The results suggest that patients should not be given pharmaceuticals blocking the renin–angiotensin–aldosterone system prior to procedures that may increase IAP. It may be beneficial, however, to reduce angiotensin II tension by volume expansion.
doi_str_mv 10.1093/ndt/gfg362
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75757528</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75757528</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-6f98190c7d4fba63c7e844487212f33a30eab4710184c066555ec3f39ed8ecb53</originalsourceid><addsrcrecordid>eNpF0M9rFTEQB_BQlPZZe-kfUHLRg7A2v7N71FJbpSCI0tJLmM1O6upu9plkpf733eU9LBnIMPNhDl9CTjl7z1kjz2NXzh_CgzTigGy4MqwSstYvyGZZ8opp1hyRVzn_Yow1wtpDcsSV1lxquSHuMgT0JdMp0D76hJCxW7qSoIK2m8Y-wkC3CXOeE1KIHf07DfOIFB-3EHM_RbpUwpWFOfqyTvpIy0-kCcpr8jLAkPFk_x-TH58uv19cVzdfrz5ffLipvKxtqUxoat4wbzsVWjDSW6yVUrUVXAQpQTKEVlnOeK08M0ZrjV4G2WBXo2-1PCZvd3e3afozYy5u7LPHYYCI05yd1esT9QLf7aBPU84Jg9umfoT0z3Hm1jjdEqfbxbngs_3VuR2xe6b7_BbwZg8gexhCguj7_Oy04I2Vq6t2rs8FH__vIf12xkqr3fXdvftohPhivil3K58AnmqNvA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75757528</pqid></control><display><type>article</type><title>Effects of increased intra-abdominal pressure and volume expansion on renal function in the rat</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Lindström, Pernilla ; Wadström, Jonas ; Ollerstam, Anna ; Johnsson, Cecilia ; Persson, A. Erik G.</creator><creatorcontrib>Lindström, Pernilla ; Wadström, Jonas ; Ollerstam, Anna ; Johnsson, Cecilia ; Persson, A. Erik G.</creatorcontrib><description>Background. The effects of increased intra-abdominal pressure (IAP) and volume expansion on renal function in the rat were studied to gain more knowledge of the oliguria seen during laparoscopic procedures and to reduce the detrimental renal effects of IAP. Methods. IAP was elevated to 5 or 10 mmHg by insufflation of CO2 and maintained for 2 h in anaesthetized and mechanically ventilated rats. Rats with normal IAP served as controls. An angiotensin II receptor I antagonist, candesartan, was given as a bolus injection and a 5% volume expansion was achieved by i.v. saline infusion. An angiotensin-converting enzyme (ACE) inhibitor was also given. Renal parameters were the glomerular filtration rate (GFR), urine production, the urinary concentrations of sodium and potassium and the osmolality in the urine. The arterial acid–base balance and blood pressure were also monitored. Results. The GFR deteriorated by 70% during pneumoperitoneum (PP) of 10 mmHg. There was a dramatic drop in sodium excretion (88–97%). With candesartan and elevated IAP, there was a drop in mean arterial pressure (from 90 to 55 mmHg) and the negative renal effects were very pronounced. Renal function was better preserved during elevated IAP in combination with volume expansion. Conclusions. Capnoperitoneum suppresses renal function, especially in combination with angiotensin II receptor 1 blockade and ACE inhibition. Volume expansion reduces the deleterious effects of PP on renal function during elevated IAP. The results suggest that patients should not be given pharmaceuticals blocking the renin–angiotensin–aldosterone system prior to procedures that may increase IAP. It may be beneficial, however, to reduce angiotensin II tension by volume expansion.</description><identifier>ISSN: 0931-0509</identifier><identifier>ISSN: 1460-2385</identifier><identifier>EISSN: 1460-2385</identifier><identifier>DOI: 10.1093/ndt/gfg362</identifier><identifier>PMID: 14551353</identifier><identifier>CODEN: NDTREA</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Angiotensin II Type 1 Receptor Blockers ; Angiotensin-Converting Enzyme Inhibitors - pharmacology ; Animals ; Benzimidazoles - pharmacology ; Biological and medical sciences ; candesartan ; Captopril - pharmacology ; Digestive system. Abdomen ; Disease Models, Animal ; Endoscopy ; glomerular filtration rate ; intra-abdominal pressure ; Investigative techniques, diagnostic techniques (general aspects) ; Kidney - drug effects ; Kidney - physiopathology ; Male ; Medical sciences ; oliguria ; pneumoperitoneum ; Pneumoperitoneum, Artificial - adverse effects ; Pressure ; Rats ; Rats, Inbred Strains ; Renin-Angiotensin System - drug effects ; Renin-Angiotensin System - physiology ; Tetrazoles - pharmacology ; volume expansion</subject><ispartof>Nephrology, dialysis, transplantation, 2003-11, Vol.18 (11), p.2269-2277</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-6f98190c7d4fba63c7e844487212f33a30eab4710184c066555ec3f39ed8ecb53</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15219733$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14551353$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lindström, Pernilla</creatorcontrib><creatorcontrib>Wadström, Jonas</creatorcontrib><creatorcontrib>Ollerstam, Anna</creatorcontrib><creatorcontrib>Johnsson, Cecilia</creatorcontrib><creatorcontrib>Persson, A. Erik G.</creatorcontrib><title>Effects of increased intra-abdominal pressure and volume expansion on renal function in the rat</title><title>Nephrology, dialysis, transplantation</title><addtitle>Nephrol. Dial. Transplant</addtitle><description>Background. The effects of increased intra-abdominal pressure (IAP) and volume expansion on renal function in the rat were studied to gain more knowledge of the oliguria seen during laparoscopic procedures and to reduce the detrimental renal effects of IAP. Methods. IAP was elevated to 5 or 10 mmHg by insufflation of CO2 and maintained for 2 h in anaesthetized and mechanically ventilated rats. Rats with normal IAP served as controls. An angiotensin II receptor I antagonist, candesartan, was given as a bolus injection and a 5% volume expansion was achieved by i.v. saline infusion. An angiotensin-converting enzyme (ACE) inhibitor was also given. Renal parameters were the glomerular filtration rate (GFR), urine production, the urinary concentrations of sodium and potassium and the osmolality in the urine. The arterial acid–base balance and blood pressure were also monitored. Results. The GFR deteriorated by 70% during pneumoperitoneum (PP) of 10 mmHg. There was a dramatic drop in sodium excretion (88–97%). With candesartan and elevated IAP, there was a drop in mean arterial pressure (from 90 to 55 mmHg) and the negative renal effects were very pronounced. Renal function was better preserved during elevated IAP in combination with volume expansion. Conclusions. Capnoperitoneum suppresses renal function, especially in combination with angiotensin II receptor 1 blockade and ACE inhibition. Volume expansion reduces the deleterious effects of PP on renal function during elevated IAP. The results suggest that patients should not be given pharmaceuticals blocking the renin–angiotensin–aldosterone system prior to procedures that may increase IAP. It may be beneficial, however, to reduce angiotensin II tension by volume expansion.</description><subject>Angiotensin II Type 1 Receptor Blockers</subject><subject>Angiotensin-Converting Enzyme Inhibitors - pharmacology</subject><subject>Animals</subject><subject>Benzimidazoles - pharmacology</subject><subject>Biological and medical sciences</subject><subject>candesartan</subject><subject>Captopril - pharmacology</subject><subject>Digestive system. Abdomen</subject><subject>Disease Models, Animal</subject><subject>Endoscopy</subject><subject>glomerular filtration rate</subject><subject>intra-abdominal pressure</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Kidney - drug effects</subject><subject>Kidney - physiopathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>oliguria</subject><subject>pneumoperitoneum</subject><subject>Pneumoperitoneum, Artificial - adverse effects</subject><subject>Pressure</subject><subject>Rats</subject><subject>Rats, Inbred Strains</subject><subject>Renin-Angiotensin System - drug effects</subject><subject>Renin-Angiotensin System - physiology</subject><subject>Tetrazoles - pharmacology</subject><subject>volume expansion</subject><issn>0931-0509</issn><issn>1460-2385</issn><issn>1460-2385</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpF0M9rFTEQB_BQlPZZe-kfUHLRg7A2v7N71FJbpSCI0tJLmM1O6upu9plkpf733eU9LBnIMPNhDl9CTjl7z1kjz2NXzh_CgzTigGy4MqwSstYvyGZZ8opp1hyRVzn_Yow1wtpDcsSV1lxquSHuMgT0JdMp0D76hJCxW7qSoIK2m8Y-wkC3CXOeE1KIHf07DfOIFB-3EHM_RbpUwpWFOfqyTvpIy0-kCcpr8jLAkPFk_x-TH58uv19cVzdfrz5ffLipvKxtqUxoat4wbzsVWjDSW6yVUrUVXAQpQTKEVlnOeK08M0ZrjV4G2WBXo2-1PCZvd3e3afozYy5u7LPHYYCI05yd1esT9QLf7aBPU84Jg9umfoT0z3Hm1jjdEqfbxbngs_3VuR2xe6b7_BbwZg8gexhCguj7_Oy04I2Vq6t2rs8FH__vIf12xkqr3fXdvftohPhivil3K58AnmqNvA</recordid><startdate>20031101</startdate><enddate>20031101</enddate><creator>Lindström, Pernilla</creator><creator>Wadström, Jonas</creator><creator>Ollerstam, Anna</creator><creator>Johnsson, Cecilia</creator><creator>Persson, A. Erik G.</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20031101</creationdate><title>Effects of increased intra-abdominal pressure and volume expansion on renal function in the rat</title><author>Lindström, Pernilla ; Wadström, Jonas ; Ollerstam, Anna ; Johnsson, Cecilia ; Persson, A. Erik G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-6f98190c7d4fba63c7e844487212f33a30eab4710184c066555ec3f39ed8ecb53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Angiotensin II Type 1 Receptor Blockers</topic><topic>Angiotensin-Converting Enzyme Inhibitors - pharmacology</topic><topic>Animals</topic><topic>Benzimidazoles - pharmacology</topic><topic>Biological and medical sciences</topic><topic>candesartan</topic><topic>Captopril - pharmacology</topic><topic>Digestive system. Abdomen</topic><topic>Disease Models, Animal</topic><topic>Endoscopy</topic><topic>glomerular filtration rate</topic><topic>intra-abdominal pressure</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Kidney - drug effects</topic><topic>Kidney - physiopathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>oliguria</topic><topic>pneumoperitoneum</topic><topic>Pneumoperitoneum, Artificial - adverse effects</topic><topic>Pressure</topic><topic>Rats</topic><topic>Rats, Inbred Strains</topic><topic>Renin-Angiotensin System - drug effects</topic><topic>Renin-Angiotensin System - physiology</topic><topic>Tetrazoles - pharmacology</topic><topic>volume expansion</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lindström, Pernilla</creatorcontrib><creatorcontrib>Wadström, Jonas</creatorcontrib><creatorcontrib>Ollerstam, Anna</creatorcontrib><creatorcontrib>Johnsson, Cecilia</creatorcontrib><creatorcontrib>Persson, A. Erik G.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Nephrology, dialysis, transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lindström, Pernilla</au><au>Wadström, Jonas</au><au>Ollerstam, Anna</au><au>Johnsson, Cecilia</au><au>Persson, A. Erik G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of increased intra-abdominal pressure and volume expansion on renal function in the rat</atitle><jtitle>Nephrology, dialysis, transplantation</jtitle><addtitle>Nephrol. Dial. Transplant</addtitle><date>2003-11-01</date><risdate>2003</risdate><volume>18</volume><issue>11</issue><spage>2269</spage><epage>2277</epage><pages>2269-2277</pages><issn>0931-0509</issn><issn>1460-2385</issn><eissn>1460-2385</eissn><coden>NDTREA</coden><abstract>Background. The effects of increased intra-abdominal pressure (IAP) and volume expansion on renal function in the rat were studied to gain more knowledge of the oliguria seen during laparoscopic procedures and to reduce the detrimental renal effects of IAP. Methods. IAP was elevated to 5 or 10 mmHg by insufflation of CO2 and maintained for 2 h in anaesthetized and mechanically ventilated rats. Rats with normal IAP served as controls. An angiotensin II receptor I antagonist, candesartan, was given as a bolus injection and a 5% volume expansion was achieved by i.v. saline infusion. An angiotensin-converting enzyme (ACE) inhibitor was also given. Renal parameters were the glomerular filtration rate (GFR), urine production, the urinary concentrations of sodium and potassium and the osmolality in the urine. The arterial acid–base balance and blood pressure were also monitored. Results. The GFR deteriorated by 70% during pneumoperitoneum (PP) of 10 mmHg. There was a dramatic drop in sodium excretion (88–97%). With candesartan and elevated IAP, there was a drop in mean arterial pressure (from 90 to 55 mmHg) and the negative renal effects were very pronounced. Renal function was better preserved during elevated IAP in combination with volume expansion. Conclusions. Capnoperitoneum suppresses renal function, especially in combination with angiotensin II receptor 1 blockade and ACE inhibition. Volume expansion reduces the deleterious effects of PP on renal function during elevated IAP. The results suggest that patients should not be given pharmaceuticals blocking the renin–angiotensin–aldosterone system prior to procedures that may increase IAP. It may be beneficial, however, to reduce angiotensin II tension by volume expansion.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>14551353</pmid><doi>10.1093/ndt/gfg362</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0931-0509
ispartof Nephrology, dialysis, transplantation, 2003-11, Vol.18 (11), p.2269-2277
issn 0931-0509
1460-2385
1460-2385
language eng
recordid cdi_proquest_miscellaneous_75757528
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors - pharmacology
Animals
Benzimidazoles - pharmacology
Biological and medical sciences
candesartan
Captopril - pharmacology
Digestive system. Abdomen
Disease Models, Animal
Endoscopy
glomerular filtration rate
intra-abdominal pressure
Investigative techniques, diagnostic techniques (general aspects)
Kidney - drug effects
Kidney - physiopathology
Male
Medical sciences
oliguria
pneumoperitoneum
Pneumoperitoneum, Artificial - adverse effects
Pressure
Rats
Rats, Inbred Strains
Renin-Angiotensin System - drug effects
Renin-Angiotensin System - physiology
Tetrazoles - pharmacology
volume expansion
title Effects of increased intra-abdominal pressure and volume expansion on renal function in the rat
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T14%3A54%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20increased%20intra-abdominal%20pressure%20and%20volume%20expansion%20on%20renal%20function%20in%20the%20rat&rft.jtitle=Nephrology,%20dialysis,%20transplantation&rft.au=Lindstro%CC%88m,%20Pernilla&rft.date=2003-11-01&rft.volume=18&rft.issue=11&rft.spage=2269&rft.epage=2277&rft.pages=2269-2277&rft.issn=0931-0509&rft.eissn=1460-2385&rft.coden=NDTREA&rft_id=info:doi/10.1093/ndt/gfg362&rft_dat=%3Cproquest_cross%3E75757528%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75757528&rft_id=info:pmid/14551353&rfr_iscdi=true